What is the Synthetic Oligonucleotides market size?

The Synthetic Oligonucleotides market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Synthetic Oligonucleotides market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Synthetic Oligonucleotides market?

Increasing demand for genetic research and rising awareness of synthetic biology drive the market.

What are the challenges faced by the Synthetic Oligonucleotides market?

High development costs and stringent regulatory requirements hinder market growth.

Which regions lead the Synthetic Oligonucleotides market?

North America and Europe are the leading regions due to strong research infrastructure.

Who are the top companies in the Synthetic Oligonucleotides market?

Leading companies include Thermo Fisher, Agilent, and Illumina, driving innovation.

What are the future opportunities in the Synthetic Oligonucleotides market?

Personalized medicine and gene editing technologies offer significant future outlook.

How does technology impact the Synthetic Oligonucleotides market?

Advances in sequencing and synthesis technologies improve efficiency and reduce costs.

What is the regulatory landscape for the Synthetic Oligonucleotides market?

Regulatory bodies like FDA and EMA ensure compliance with safety and efficacy standards.

What is the current future outlook for the Synthetic Oligonucleotides market?

The market is expected to witness significant growth due to increasing applications.

Synthetic Oligonucleotides Market Growing at CAGR — 2026 Report

Synthetic Oligonucleotides by Application (Genetic Testing, Pharmacy, Other), by Types (Column-Based Oligos, Array-Based Oligos), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Synthetic Oligonucleotides Market Overview

The Synthetic Oligonucleotides market refers to the industry involved in the design, production, and application of synthetic oligonucleotides, which are short DNA or RNA molecules. As the Synthetic Oligonucleotides market size is estimated to be around $1.4 billion, the growth outlook and market forecast indicate a promising expansion, driven by advancements in genetic engineering, gene editing, and diagnostic technologies, with the global industry expansion expected to reach $4.2 billion by 2033. The scope of this market encompasses various synthetic oligonucleotide types, including antisense oligonucleotides, siRNA, and aptamers, with applications in therapeutics, diagnostics, and research.

Loading chart…

The Synthetic Oligonucleotides market is expected to grow at a CAGR of 15%, driven by macro drivers such as increasing demand for targeted therapies, advancements in gene editing technologies, and growing investments in genomic research. Key forces shaping the industry include technology shifts, such as the development of new synthesis methods and delivery systems, regulations, such as those related to gene editing and biosafety, and competitive intensity, with major players investing in R&D and strategic partnerships. The largest region is currently North America, while the fastest-growing region is Asia-Pacific, driven by increasing investments in biotechnology and genomics.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck KGaA; Thermo Fisher Scientific; Creative Biolabs; Danaher Corporation; Eurofins Scientific SE; Agilent Technologies, Inc.; GE Healthcare; Kaneka Eurogentec S.A.; GeneDesign, Inc.; LGC Biosearch Technologies; Bio-synthesis Inc.; GeneWorks Pty Ltd; Integrated DNA Technologies, Inc.; BioAutomation; Twist Bioscience
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Synthetic Oligonucleotides market is poised for significant growth, driven by advances in gene editing and genomics technologies. This section outlines the key dynamics shaping the market, including growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Increasing demand for Synthetic Oligonucleotides in cancer research and precision medicine, driven by their potential to enable targeted therapies and improve patient outcomes

Advances in DNA synthesis technologies, which have improved the efficiency, accuracy, and scalability of Synthetic Oligonucleotides production, contributing to the growth forecast of the Synthetic Oligonucleotides market size

Restraints2 items

High development costs and regulatory hurdles, which can limit the accessibility of Synthetic Oligonucleotides to smaller research institutions and biotech companies, affecting the overall Synthetic Oligonucleotides market

Concerns over intellectual property protection and patent infringement, which can create uncertainty and risks for companies investing in Synthetic Oligonucleotides research and development

Opportunities2 items

Emerging applications of Synthetic Oligonucleotides in agricultural biotechnology and synthetic biology, which offer new opportunities for growth and innovation in the Synthetic Oligonucleotides market

Increasing adoption of personalized medicine and liquid biopsies, which is driving demand for Synthetic Oligonucleotides and contributing to the growth forecast of the Synthetic Oligonucleotides market size

Challenges2 items

Ensuring the quality and purity of Synthetic Oligonucleotides, which is critical for their effective use in research and therapeutic applications, and addressing the challenges associated with scaling up production

Addressing the regulatory frameworks and standardization of Synthetic Oligonucleotides, which can vary across regions and countries, affecting the growth of the Synthetic Oligonucleotides market

Market Segmentation

Loading chart…

The Synthetic Oligonucleotides market can be segmented based on Application, which includes subtypes such as research, diagnostics, and therapeutics. The research segment holds a significant share of the market, driven by the increasing demand for synthetic oligonucleotides in molecular biology and genetic engineering. The diagnostics segment is also expected to grow, fueled by the rising adoption of synthetic oligonucleotides in diagnostic tests and kits. Understanding the Synthetic Oligonucleotides segmentation is crucial for businesses to identify opportunities and make informed decisions.

The Types segment of the Synthetic Oligonucleotides market includes subtypes such as DNA, RNA, and modified oligonucleotides. DNA oligonucleotides are the most commonly used type, accounting for a significant share of the market. RNA oligonucleotides are also gaining traction, driven by their increasing application in RNA interference and gene silencing. Modified oligonucleotides, such as phosphorothioate and phosphoramidate, are also being developed for specific applications, contributing to the growth of the overall Synthetic Oligonucleotides market size. Analyzing the market taxonomy is essential for understanding the competitive landscape and identifying opportunities for growth.

Synthetic Oligonucleotides Segmentation Breakdown7 items

Application

Genetic Testing

Pharmacy

Other

Types

Column-Based Oligos

Array-Based Oligos

Regional Insights

Loading chart…

The Synthetic Oligonucleotides market growth is anticipated to be driven by various regional factors. North America is the largest region, accounting for approximately 40% of the market share, driven by key drivers such as high adoption rates of Synthetic Oligonucleotides in research and development, favorable policies and investments in the biotechnology sector, and a mature ecosystem with established infrastructure. In contrast, Asia Pacific is the fastest-growing region, with a regional forecast indicating a significant increase in demand due to rising demographics and growing infrastructure in countries such as China and India.

In Europe, key drivers include increasing investments in Synthetic Oligonucleotides research, a highly developed infrastructure for biotechnology, and a strong ecosystem with many established companies. Latin America and Middle East & Africa are also expected to contribute to the Synthetic Oligonucleotides market growth, driven by factors such as growing adoption rates, improving policies, and increasing demographics.

Regional Key Drivers5 items

North America: high adoption rates, favorable policies, and mature ecosystem

Asia Pacific: rising demographics, growing infrastructure, and increasing investments

Europe: increasing investments, highly developed infrastructure, and strong ecosystem

Latin America: growing adoption rates, improving policies, and increasing demographics

Middle East & Africa: growing adoption rates, improving policies, and increasing demographics

Competitive Landscape

The Synthetic Oligonucleotides market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Synthetic Oligonucleotides competitive landscape is characterized by high competition, with key players investing in research and development to maintain their market position. Global players are expanding their presence in emerging markets, while local companies are focusing on customized products and services to cater to regional demand.

Companies in the Synthetic Oligonucleotides market are adopting various strategies to differentiate themselves, including mergers and acquisitions, partnerships, product launches, and expansion into new regions. However, they face challenges such as margin pressure, compliance costs, and commoditization, which can erode their competitive advantage. To stay ahead, companies are focusing on technology innovation, service model differentiation, and channel strength. The following companies are implementing these strategies:

Merck KGaA: regional expansion

Thermo Fisher Scientific: innovation pipeline

Creative Biolabs: premium pricing

Danaher Corporation: vertical integration

Eurofins Scientific SE: OEM tie-ups

Agilent Technologies, Inc.: local manufacturing

Key Synthetic Oligonucleotides Companies15 items

Merck KGaA

Thermo Fisher Scientific

Creative Biolabs

Danaher Corporation

Eurofins Scientific SE

Agilent Technologies, Inc.

GE Healthcare

Kaneka Eurogentec S.A.

GeneDesign, Inc.

LGC Biosearch Technologies

Bio-synthesis Inc.

GeneWorks Pty Ltd

Integrated DNA Technologies, Inc.

BioAutomation

Twist Bioscience

Market Ecosystem

The Synthetic Oligonucleotides ecosystem spans upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. This complex network creates and captures value through the development, manufacturing, and distribution of synthetic oligonucleotides. Understanding the Synthetic Oligonucleotides ecosystem requires a thorough value chain analysis, from raw material sourcing to end-user applications.

Raw material suppliers — providing chemical building blocks

Technology providers — developing synthesis and purification methods

OEMs/manufacturers — producing synthetic oligonucleotides

Distributors/channel partners — delivering products to end users

Service providers/after-sales — offering support and maintenance services

End users/buyers — utilizing synthetic oligonucleotides in research and applications

Regulators/standards bodies — establishing guidelines and approvals

In the Synthetic Oligonucleotides ecosystem, control points are influenced by regulators, technology providers, and end users, who drive adoption through demand and standards. Dependency risks arise from input constraints, such as raw material availability, and regulatory approvals. Switching costs and partnerships can be significant, particularly for manufacturers and end users, while interoperability requirements may vary by region. As the ecosystem differs by region, understanding these nuances is crucial for navigating the global Synthetic Oligonucleotides market.

Recent Industry Insights

The Synthetic Oligonucleotides industry trends have witnessed significant developments over the last 12-18 months, with a focus on innovation and collaboration. Recent partnerships between key players have accelerated the development of novel therapies, while mergers and acquisitions have led to the expansion of product portfolios. Furthermore, several companies have launched new products and technologies, enhancing the industry's capabilities. Regulatory changes have also played a crucial role, with updated guidelines facilitating the approval of synthetic oligonucleotides-based treatments. A notable shift in consumer trends has been observed, with an increased demand for personalized medicines, driving the growth of the Synthetic Oligonucleotides market. Additionally, funding rounds and expansions have been announced, providing a boost to the industry's research and development initiatives.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Synthetic Oligonucleotides market. The market attractiveness is moderate, driven by increasing demand for genetic research and therapeutic applications. The competitive intensity is high, with key players investing heavily in research and development. The long-term outlook for the Synthetic Oligonucleotides market outlook is promising, with potential applications in personalized medicine and gene editing.

The innovation landscape is rapidly evolving, with advancements in synthesis technologies and delivery mechanisms. However, the demand–supply balance is a concern, with potential shortages of raw materials. Key risk factors include regulatory uncertainties and intellectual property disputes. Overall, the Synthetic Oligonucleotides market presents opportunities for growth, but companies must navigate these challenges to succeed.

11 items

1. Executive Summary

2. Synthetic Oligonucleotides Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Synthetic Oligonucleotides Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Synthetic Oligonucleotides Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Genetic Testing

6.1.2. Pharmacy

6.1.3. Other

6.2. Global Synthetic Oligonucleotides Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Column-Based Oligos

6.2.2. Array-Based Oligos

6.3. Global Synthetic Oligonucleotides Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Synthetic Oligonucleotides Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Synthetic Oligonucleotides Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Synthetic Oligonucleotides Market Competition by Key Manufacturers

8.1. Global Synthetic Oligonucleotides Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Synthetic Oligonucleotides: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Merck KGaA

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Thermo Fisher Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Creative Biolabs

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Danaher Corporation

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Eurofins Scientific SE

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Agilent Technologies, Inc.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. GE Healthcare

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Kaneka Eurogentec S.A.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. GeneDesign, Inc.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. LGC Biosearch Technologies

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Bio-synthesis Inc.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. GeneWorks Pty Ltd

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Integrated DNA Technologies, Inc.

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. BioAutomation

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Twist Bioscience

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Synthetic Oligonucleotides Market

Figure 4: Global Synthetic Oligonucleotides Market: Drivers

Figure 5: Global Synthetic Oligonucleotides Market: Challenges

Figure 6: Global Synthetic Oligonucleotides Market: Trends

Figure 7: Global Synthetic Oligonucleotides Market: Opportunity

Figure 8: Global Synthetic Oligonucleotides Market: Restraint

Figure 9: Global Synthetic Oligonucleotides Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Synthetic Oligonucleotides Market Value (USD Million) By Region

Figure 15: Global Synthetic Oligonucleotides Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Synthetic Oligonucleotides Market Value (USD Million) By Region

Figure 23: Global Synthetic Oligonucleotides Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Synthetic Oligonucleotides Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Synthetic Oligonucleotides Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Synthetic Oligonucleotides Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Synthetic Oligonucleotides Market Value (USD Million) By Region

Table 10: Global Synthetic Oligonucleotides Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Synthetic Oligonucleotides Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Synthetic Oligonucleotides Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Synthetic Oligonucleotides Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Merck KGaA Basic Information And Sales Area

Table 31: Merck KGaA. Products Portfolio

Table 32: Thermo Fisher Scientific Basic Information And Sales Area

Table 33: Thermo Fisher Scientific. Products Portfolio

Table 34: Creative Biolabs Basic Information And Sales Area

Table 35: Creative Biolabs. Products Portfolio

Table 36: Danaher Corporation Basic Information And Sales Area

Table 37: Danaher Corporation. Products Portfolio

Table 38: Eurofins Scientific SE Basic Information And Sales Area

Table 39: Eurofins Scientific SE. Products Portfolio

Table 40: Agilent Technologies, Inc. Basic Information And Sales Area

Table 41: Agilent Technologies, Inc.. Products Portfolio

Table 42: GE Healthcare Basic Information And Sales Area

Table 43: GE Healthcare. Products Portfolio

Table 44: Kaneka Eurogentec S.A. Basic Information And Sales Area

Table 45: Kaneka Eurogentec S.A.. Products Portfolio

Table 46: GeneDesign, Inc. Basic Information And Sales Area

Table 47: GeneDesign, Inc.. Products Portfolio

Table 48: LGC Biosearch Technologies Basic Information And Sales Area

Table 49: LGC Biosearch Technologies. Products Portfolio

Table 50: Bio-synthesis Inc. Basic Information And Sales Area

Table 51: Bio-synthesis Inc.. Products Portfolio

Table 52: GeneWorks Pty Ltd Basic Information And Sales Area

Table 53: GeneWorks Pty Ltd. Products Portfolio

Table 54: Integrated DNA Technologies, Inc. Basic Information And Sales Area

Table 55: Integrated DNA Technologies, Inc.. Products Portfolio

Table 56: BioAutomation Basic Information And Sales Area

Table 57: BioAutomation. Products Portfolio

Table 58: Twist Bioscience Basic Information And Sales Area

Table 59: Twist Bioscience. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Synthetic Oligonucleotides Market Value (USD Million) By Region

Table 65: Global Synthetic Oligonucleotides Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Synthetic Oligonucleotides Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck KGaA; Thermo Fisher Scientific; Creative Biolabs; Danaher Corporation; Eurofins Scientific SE; Agilent Technologies, Inc.; GE Healthcare; Kaneka Eurogentec S.A.; GeneDesign, Inc.; LGC Biosearch Technologies; Bio-synthesis Inc.; GeneWorks Pty Ltd; Integrated DNA Technologies, Inc.; BioAutomation; Twist Bioscience
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Increasing demand for Synthetic Oligonucleotides in cancer research and precision medicine, driven by their potential to enable targeted therapies and improve patient outcomes

Restraints2 items

Concerns over intellectual property protection and patent infringement, which can create uncertainty and risks for companies investing in Synthetic Oligonucleotides research and development

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Synthetic Oligonucleotides Segmentation Breakdown7 items

Application

Genetic Testing

Pharmacy

Other

Types

Column-Based Oligos

Array-Based Oligos

Regional Insights

Loading chart…

Regional Key Drivers5 items

North America: high adoption rates, favorable policies, and mature ecosystem

Asia Pacific: rising demographics, growing infrastructure, and increasing investments

Europe: increasing investments, highly developed infrastructure, and strong ecosystem

Latin America: growing adoption rates, improving policies, and increasing demographics

Middle East & Africa: growing adoption rates, improving policies, and increasing demographics

Competitive Landscape

Merck KGaA: regional expansion

Thermo Fisher Scientific: innovation pipeline

Creative Biolabs: premium pricing

Danaher Corporation: vertical integration

Eurofins Scientific SE: OEM tie-ups

Agilent Technologies, Inc.: local manufacturing

Key Synthetic Oligonucleotides Companies15 items

Merck KGaA

Thermo Fisher Scientific

Creative Biolabs

Danaher Corporation

Eurofins Scientific SE

Agilent Technologies, Inc.

GE Healthcare

Kaneka Eurogentec S.A.

GeneDesign, Inc.

LGC Biosearch Technologies

Bio-synthesis Inc.

GeneWorks Pty Ltd

Integrated DNA Technologies, Inc.

BioAutomation

Twist Bioscience

Market Ecosystem

Raw material suppliers — providing chemical building blocks

Technology providers — developing synthesis and purification methods

OEMs/manufacturers — producing synthetic oligonucleotides

Distributors/channel partners — delivering products to end users

Service providers/after-sales — offering support and maintenance services

End users/buyers — utilizing synthetic oligonucleotides in research and applications

Regulators/standards bodies — establishing guidelines and approvals

Recent Industry Insights

Analyst Overview

Table of Contents